Opinion: The future of pharmaceutical R&D: somewhere between open and reverse innovation?-Reference-Cited by-同舟云学术

Opinion: The future of pharmaceutical R&D: somewhere between open and reverse innovation?

Published:2010-09 Issue:9 Volume:2 Page:1399-1403
ISSN:1756-8919
Container-title:Future Medicinal Chemistry
language:en
Short-container-title:Future Medicinal Chemistry

Author:

Talaga Patrice¹

Affiliation:

1. Director of Chemistry Outsourcing at UCB, Chemin du Foriest, B-1420 Braine-l’Alleud, Belgium.

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.future-science.com/doi/pdf/10.4155/fmc.10.213

Reference14 articles.

1. How to improve R&D productivity: the pharmaceutical industry's grand challenge

2. ChesbroughHW. Open innovation: the new imperative for creating and profiting from technology. Harvard Business School Press, Boston, MA, USA (2003).

3. Open Innovation: share or die…

4. Is open innovation the way forward for big pharma?

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reverse Innovation in Retrospect and Prospect Quo Vadis?;IEEE Transactions on Engineering Management;2023

2. A Comprehensive Review on Strategies for New Drug Discovery and Enhanced Productivity in Research and Development: Recent Advancements and Future Prospectives;Mini-Reviews in Organic Chemistry;2021-05-27

3. Innovation Dynamics and Globalization Trends of High-Throughput Bioanalytical Methods from a Literature Survey;Bioanalysis;2020-06

4. Exploring the Future of Graduate Education in Pharmaceutical Fields;Medical Science Educator;2019-12-03

5. Reverse innovation: a systematic literature review;International Journal of Emerging Markets;2017-04-18